News

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
Government data indicate the LP.8.1 strain — a subvariant of the previously targeted JN.1 strain — accounts for about 70% of ...